Chemical Warfare Agent Contract With US/UK Special Operations

US $100 Million of Testing In 2017

Sponsored
Message: PyroGenesis Announces Contract for Second Phase Lab Scale Testing Program Totalling CAN$170,000 with HPQ Silicon Resources Inc.

PyroGenesis Announces Contract for Second Phase Lab Scale Testing Program Totalling CAN$170,000 with HPQ Silicon Resources Inc.

posted on May 04, 2017 08:35AM

MONTREAL, QUEBEC--(May 4, 2017) - PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX VENTURE:PYR)(OTCQB:PYRNF), a high-tech company (the "Company" or "PyroGenesis") that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, is pleased to announce today that it has signed a contract for CAN$170,000 with HPQ Silicon Resources Inc. ("HPQ"), wherein PyroGenesis will provide a second phase of Process Characterization Testing (the "Testing"), using a newly upgraded version of the lab scale PUREVAP™ Quartz Reduction Reactor (the "Reactor").

The purpose of the Testing is to build upon the bench scale success made to date and to push the design of the lab scale Reactor to a point that will allow it to operate in a semi-batch mode to produce silicon (Si) samples. The Testing will use higher purity feedstock (99.5% SiO2.) with a goal of producing at least 5N (99.999% Si) Solar Grade Silicon Metal at lab scale.

This Testing program will take place over the next several months, and will be in conjunction with the delivery of the pilot plant Reactor scheduled for October 2017. The objectives of these metallurgical tests will be, amongst others, to: (i) generate and collect data that can be used for the scale-up of the lab scale Reactor and ultimately, for the commercial scale-up of the PUREVAP™ process; and (ii) to continue testing different purification alternatives.

PyroGenesis will provide HPQ with samples for third party independent purity validation as well as a milestones report and final report summarizing the results and analysis.

"We are eager to start this additional testing phase," said Pierre Carabin, Chief Technology Officer of PyroGenesis. "This new testing will allow us to validate the design of pilot plant Reactor and to further improve the product purity."

"The further we proceed in this project, the more confident we are that we have found a plasma-based application that can be applied to quartz in a commercial setting," said P. Peter Pascali, President and CEO of PyroGenesis. "We are very pleased with the results to date. That is not to say we have succeeded, will succeed, or that there won't be challenges ahead. To the contrary, we fully expect there will be challenges as in any project; however we are certain that we will meet those challenges as we have with other projects, and find the best possible solution, if any. Once again, we are extremely pleased with the success of the project to date and the results that we have achieved."

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. PyroGenesis provides engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Its core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Its operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect", "in the process" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company's ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

PyroGenesis Canada Inc.
Rodayna Kafal
VP, Investor Relations and Communications
(514) 937-0002
[email protected] or [email protected]

Share
New Message
Please login to post a reply